(Total Views: 632)
Posted On: 12/27/2020 10:52:22 AM
Post# of 145875
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: Goosebumps #69813
My previous reasoning was that the data for interim was between p= .05 and p=.005. The DSMC and of course the FDA would have wanted to see p= .005 for a trial halt for efficacy due to the very broad confidence interval or power. The number of patients for the full trial would have been set up so p= .05 and the 390 patients would have a suitable confidence interval.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)